Secondary prevention of dementia: combining risk factors and scalable screening technology by Ojakäär, T, Koychev, I

Cognitive-behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review by Koychev, I, Okai, D

Correlation of Alzheimer’s Disease neuropathologic staging with amyloid and tau scintigraphic imaging biomarkers by Koychev, I, Hofer, M, Friedman, N

Reply to: Letter to the editor: Sodium nitroprusside for schizophrenia: Could methodological variables account for the different results obtained? by Stone, J, Koychev, I, Reilly, T, McGuire, P

Blood-based ATN biomarkers of Alzheimer’s disease: a meta-analysis by Koychev, I, Jansen, K, Dette, A, Shi, L, Holling, H

Effects of acute ketamine infusion on visual working memory: event-related potentials by Koychev, I, William Deakin, J, El-Deredy, W, Haenschel, C

Brexpiprazole versus placebo or other antidepressive agents for treating depression by Ralovska, S, Koychev, I, De Crescenzo, F, Marinov, P, Cipriani, A

Digital technologies for the assessment of cognition: A clinical review by Chinner, A, Blane, J, Lancaster, C, Hinds, C, Koychev, I

Sudden-onset catatonia following Clozapine withdrawal: a case report by Koychev, I, Hadjiphilippou, S, Lynch, J, Whelan, P, MacCabe, J

Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study by Henshall, C, Cipriani, A, Ruvolo, D, Macdonald, O, Wolters, L, Koychev, I

Evaluating the feasibility of frequent cognitive assessment using the Mezurio smartphone app: observational and interview study in adults with elevated dementia risk by Lancaster, C, Koychev, I, Blane, J, Chinner, A, Wolters, L, Hinds, C

12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study by De Giorgi, R, Koychev, I, Adler, A, Cowen, P, Harmer, C, Harrison, P

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451 by Firouzian, A, Whittington, A, Searle, G, Koychev, I, Zamboni, G, Lovestone, S, Gunn, R

Inflammatory proteins associated with Alzheimer’s disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial by Koychev, I, Reid, G, Nguyen, M, Mentz, RJ, Joyce, D, Shah, SH, Holman, RR

Gallery Game: Smartphone-based assessment of long-term memory in adults at risk of Alzheimer’s disease by Lancaster, C, Koychev, I, Blane, J, Chinner, A, Chatham, C, Taylor, K, Hinds, C

The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial by Stone, J, Morrison, P, Gao, F, Koychev, I, Reilly, T, Kolanko, M, Mohammadinasab, A, Kapur, S, McGuire, P

Prediction of rapid amyloid and phospotylated-tau accumulation in cognitively healthy individuals by Koychev, I, Vaci, N, Bilgel, M, An, Y, Muniz, GT, Wong, DF, Gallacher, J, Mogekhar, A, Albert, M, Resnick, S

Prediction of Alzheimer's disease biomarker status defined by the ‘ATN Framework’ among cognitively healthy individuals: Results from the EPAD longitudinal cohort study by Calvin, C, Calvin, C, de Boer, C, Raymont, V, Gallacher, J, Koychev, I, The European Prevention of Alzheimer’s Dementia (EPAD) Consortium

Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia study by Shah, SN, Dounavi, M, Malhotra, PA, Lawlor, B, Naci, L, Koychev, I, Ritchie, CW, Ritchie, K, O’Brien, JT

Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study by Vaci, N, Koychev, I, Kim, C-H, Kormilitzin, A, Liu, Q, Lucas, C, Dehghan, A, Nenadic, G, Nevado-Holgado, A